StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
1127
This month
47
This week
13
This year
47
Yesterday
1
Publishing Date
2023 - 01 - 26
5
2023 - 01 - 09
6
2022 - 12 - 22
5
2022 - 11 - 07
5
2022 - 11 - 03
5
2022 - 08 - 08
7
2022 - 08 - 04
7
2022 - 07 - 28
5
2022 - 07 - 18
7
2022 - 06 - 28
5
2022 - 06 - 20
5
2022 - 06 - 14
5
2022 - 06 - 13
6
2022 - 06 - 07
5
2022 - 06 - 06
7
2022 - 06 - 03
5
2022 - 05 - 11
7
2022 - 04 - 26
7
2022 - 04 - 11
7
2022 - 03 - 01
8
2022 - 02 - 24
6
2022 - 02 - 22
5
2021 - 12 - 13
5
2021 - 12 - 03
5
2021 - 11 - 04
6
2021 - 10 - 18
5
2021 - 10 - 13
5
2021 - 09 - 30
6
2021 - 09 - 28
7
2021 - 09 - 09
5
2021 - 09 - 07
5
2021 - 08 - 18
5
2021 - 08 - 16
6
2021 - 08 - 09
6
2021 - 08 - 03
8
2021 - 07 - 29
6
2021 - 07 - 14
5
2021 - 07 - 09
5
2021 - 06 - 29
6
2021 - 06 - 24
5
2021 - 06 - 22
5
2021 - 06 - 21
5
2021 - 06 - 17
5
2021 - 06 - 08
5
2021 - 06 - 07
6
2021 - 06 - 03
5
2021 - 06 - 01
6
2021 - 05 - 20
5
2021 - 05 - 11
5
2021 - 05 - 06
4
2021 - 05 - 05
4
2021 - 05 - 04
6
2021 - 04 - 20
7
2021 - 04 - 14
6
2021 - 04 - 13
8
2021 - 04 - 12
4
2021 - 04 - 08
4
2021 - 04 - 07
7
2021 - 03 - 11
4
2021 - 03 - 10
4
Sector
Commercial services
8
Communications
4
Consumer non-durables
8
Consumer services
2
Distribution services
4
Electronic technology
10
Energy minerals
9
Finance
16
Finance and insurance
2
Health services
20
Health technology
1127
Manufacturing
82
Miscellaneous
1
N/a
8
Process industries
8
Producer manufacturing
6
Professional, scientific, and technical services
7
Retail trade
1
Technology services
15
Transportation
1
Wholesale trade
1
Tags
Alliances
31
Alzheimer's
16
Alzheimer’s
18
Antibody
42
Application
17
Approval
43
Biomidwest
25
Biotech
15
Biotech-bay
19
Cancer
88
Ces
29
China
36
Chinese
21
Clinical-trials-phase-iii
24
Collaboration
55
Conference
51
Covid
62
Covid-19
46
Designation
16
Diabetes
43
Disease
58
Drug
77
Earnings
38
Ev
18
Events
26
Expected
16
Fda
55
Financial results
42
For
100
Global
48
Growth
45
Health
21
Heart
21
Injection
21
Insulin
32
Iot
23
License
25
Liver
17
Market
126
Merge
18
Money
26
N/a
703
People
52
Pharma
30
Pharmaceutical
16
Phase 1
19
Phase 2
23
Phase 3
47
Positive
23
Report
64
Research
93
Results
140
Risk
22
Sabizabulin
18
Study
28
Technology
20
Therapeutics
72
Therapy
66
Treatment
131
Trial
87
Entities
Abbott laboratories
34
Abbvie inc.
73
Abcellera biologics inc
12
Ac immune sa
13
Adc therapeutics sa
13
Agios pharmaceuticals, inc.
10
Akouos, inc.
9
Alexion pharmaceuticals, inc.
43
Alnylam pharmaceuticals, inc.
34
Amgen inc.
61
Astellas pharma inc
12
Astrazeneca plc
61
Aveo pharmaceuticals, inc.
23
Bausch health companies inc.
7
Baxter international inc.
9
Becton, dickinson and company
18
Beigene, ltd.
17
Biocryst pharmaceuticals, inc.
13
Biogen inc.
8
Biontech se
9
Blueprint medicines corporation
18
Bristol-myers squibb company
79
Clovis oncology, inc.
18
Dicerna pharmaceuticals, inc.
24
Eli lilly and company
1127
Epizyme, inc.
19
Exelixis, inc.
11
Gilead sciences, inc.
28
Glaxosmithkline plc
78
Icon plc
7
Illumina, inc.
15
Incyte corporation
162
Insulet corporation
11
Johnson & johnson
111
Karyopharm therapeutics inc.
20
Medtronic plc
11
Merus n.v.
13
Mylan n.v.
21
Neos therapeutics, inc.
13
Novartis ag
83
Novo nordisk a/s
60
Omeros corporation
14
Otonomy, inc.
13
Pfizer, inc.
68
Prevail therapeutics inc.
9
Proqr therapeutics n.v.
7
Regeneron pharmaceuticals, inc.
33
Rigel pharmaceuticals, inc.
41
Sanofi
205
Takeda pharmaceutical company limited
25
Teva pharmaceutical industries limited
7
Teva pharmaceutical industries ltd
31
Thermo fisher scientific inc
8
Total se
9
Verastem, inc.
10
Veru inc.
35
Viatris inc.
13
Vir biotechnology, inc.
9
Xeris pharmaceuticals, inc.
10
Y-mabs therapeutics, inc.
18
Symbols
AAPL
687
ABB
870
ABBV
636
ABLZF
611
ABT
1020
AMGN
476
ARVL
2407
AZN
407
BDX
555
BMY
444
BNPQF
971
BNPQY
971
BNPZY
970
BSX
398
CNY
969
CSCO
598
DHR
483
ERIC
1022
EXTR
478
FNCTF
3460
FRBA
397
GE
646
GLAXF
398
GOOG
513
GOOGL
513
GSK
597
HON
1073
HUBS
1010
IBM
418
INR
972
INTC
617
JNJ
2875
LLY
1127
LTUM
528
LYV
459
MDT
868
MLPY
970
MMM
634
MS
2595
MS-PE
398
MSFT
835
NOK
477
NOKBF
460
NVO
398
NVS
728
NVSEF
525
ORCL
774
PFE
502
PHG
613
PPRUF
593
PPRUY
594
SAP
942
SAPGF
677
SNOW
517
SNY
2651
SNYNF
1706
TMO
929
TOT
995
URR
968
VZ
639
Exchanges
Amex
3
Lse
40
Nasdaq
714
Nyse
1127
Tsx
4
Crawled Date
2023 - 01 - 26
5
2023 - 01 - 09
6
2022 - 12 - 22
5
2022 - 11 - 07
5
2022 - 08 - 08
7
2022 - 08 - 04
7
2022 - 07 - 28
5
2022 - 07 - 18
6
2022 - 06 - 20
5
2022 - 06 - 14
5
2022 - 06 - 13
6
2022 - 06 - 07
6
2022 - 06 - 06
7
2022 - 06 - 03
5
2022 - 05 - 11
7
2022 - 04 - 26
7
2022 - 04 - 11
8
2022 - 03 - 01
8
2022 - 02 - 22
5
2021 - 12 - 13
5
2021 - 12 - 03
5
2021 - 11 - 04
5
2021 - 10 - 18
5
2021 - 10 - 13
5
2021 - 09 - 30
6
2021 - 09 - 28
7
2021 - 09 - 09
5
2021 - 09 - 07
5
2021 - 08 - 18
5
2021 - 08 - 16
6
2021 - 08 - 09
7
2021 - 08 - 03
8
2021 - 07 - 29
6
2021 - 07 - 16
4
2021 - 07 - 14
5
2021 - 07 - 09
5
2021 - 07 - 06
4
2021 - 06 - 29
6
2021 - 06 - 24
5
2021 - 06 - 22
6
2021 - 06 - 21
4
2021 - 06 - 16
4
2021 - 06 - 15
4
2021 - 06 - 08
5
2021 - 06 - 07
6
2021 - 06 - 03
4
2021 - 06 - 01
5
2021 - 05 - 20
5
2021 - 05 - 11
5
2021 - 05 - 10
4
2021 - 05 - 06
4
2021 - 05 - 05
4
2021 - 05 - 04
6
2021 - 04 - 20
7
2021 - 04 - 14
6
2021 - 04 - 13
10
2021 - 04 - 08
4
2021 - 04 - 07
7
2021 - 03 - 11
4
2021 - 03 - 10
4
Crawled Time
00:00
37
00:01
1
00:20
5
01:00
91
01:15
1
02:00
13
02:11
1
03:00
6
04:00
3
04:20
2
05:00
5
06:00
10
07:00
9
08:00
13
09:00
11
10:00
19
10:51
1
11:00
64
11:36
1
12:00
117
12:03
2
12:07
5
12:09
2
12:10
1
12:11
7
12:15
19
12:20
19
12:30
7
12:34
1
12:39
1
12:40
1
13:00
72
13:01
1
13:07
1
13:13
1
13:15
8
13:20
18
13:30
10
14:00
54
14:15
8
14:20
8
14:30
11
15:00
47
15:15
3
15:20
15
15:30
9
16:00
80
16:20
9
17:00
45
18:00
43
18:17
2
18:31
2
19:00
41
19:11
2
20:00
26
21:00
48
22:00
27
22:04
2
23:00
26
23:07
2
Source
brightmindsbio.com
1
investor.alkermes.com
1
investor.aveooncology.com
2
ir.cyclerion.com
1
ir.pulmatrix.com
1
ir.vaccinex.com
1
www.biospace.com
424
www.brickellbio.com
2
www.chi-med.com
1
www.clarivate.com
1
www.concertpharma.com
1
www.cowen.com
1
www.emmis.com
1
www.fda.gov
36
www.firstbankonline.com
1
www.globenewswire.com
98
www.hutch-med.com
2
www.preludetx.com
1
www.prnewswire.com
550
www.thermogenesis.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
Lly
save search
U.S. FDA Approves Jaypirca™ (pirtobrutinib), the First and Only Non-Covalent (Reversible) BTK Inhibitor, for Adult Patients with Relapsed or Refractory Mantle Cell Lymphoma After at Least Two Lines of Systemic Therapy, Including a BTK Inhibitor
Published:
2023-01-27
(Crawled : 20:00)
- biospace.com/
LLY
|
News
|
$342.1
-1.7%
0.12%
2.3M
|
Health Technology
|
-0.54%
|
O:
-0.54%
H:
0.0%
C:
0.0%
fda
for
Lilly Supports Direct Relief's Efforts to Expand Access to Medicines by Improving Cold Chain Capacity
Published:
2023-01-26
(Crawled : 17:00)
- biospace.com/
LLY
|
News
|
$342.1
-1.7%
0.12%
2.3M
|
Health Technology
|
0.06%
|
O:
1.48%
H:
0.34%
C:
-0.85%
capacity
direct
UPSHER-SMITH EXPANDS FLUOXETINE PRODUCT LINE TO INCLUDE AN ORAL SOLUTION
Published:
2023-01-26
(Crawled : 17:00)
- prnewswire.com
LLY
|
News
|
$342.1
-1.7%
0.12%
2.3M
|
Health Technology
|
0.06%
|
O:
1.48%
H:
0.34%
C:
-0.85%
solution
Myocardial Infarction (MI) Market is Projected to Grow at a Minimal CAGR of 1.61% During the Study Period (2019-2032) | Assesses DelveInsight
Published:
2023-01-26
(Crawled : 16:00)
- prnewswire.com
LLY
|
News
|
$342.1
-1.7%
0.12%
2.3M
|
Health Technology
|
0.06%
|
O:
1.48%
H:
0.34%
C:
-0.85%
study
market
Veru to Report Fiscal 2023 First Quarter Financial Results on February 9, 2023
Published:
2023-01-26
(Crawled : 14:00)
- globenewswire.com
LLY
|
News
|
$342.1
-1.7%
0.12%
2.3M
|
Health Technology
|
0.06%
|
O:
1.48%
H:
0.34%
C:
-0.85%
VERU
|
News
|
$5.91
0.0%
1.8M
|
Health Technology
|
-4.58%
|
O:
1.31%
H:
0.81%
C:
-4.52%
report
financial
results
AC Immune’s ACI-24.060 Anti-Amyloid Beta Vaccine for Alzheimer’s Shows Positive Initial Interim Safety and Immunogenicity in Phase 1b/2 ABATE Trial
Published:
2023-01-26
(Crawled : 12:20)
- globenewswire.com
LLY
|
News
|
$342.1
-1.7%
0.12%
2.3M
|
Health Technology
|
0.06%
|
O:
1.48%
H:
0.34%
C:
-0.85%
ACIU
|
$2.33
-2.92%
-3.0%
130K
|
Health Technology
|
5.73%
|
O:
14.1%
H:
0.0%
C:
-7.34%
aci-24
for
vaccine
trial
alzheimer’s
positive
aci-24.060
anti-amyloid beta
Global Psoriasis Therapeutics Market Report to 2031 - Featuring Abbvie, Amgen, Bausch Health, LEO Pharma and Novan Among Others
Published:
2023-01-25
(Crawled : 21:00)
- prnewswire.com
NVSEF
|
News
4 d
|
$90.0
0
|
Health Technology
|
-1.1%
|
O:
-1.1%
H:
0.0%
C:
0.0%
VTRS
|
$11.89
2.15%
2.1%
9.9M
|
Health Technology
|
0.69%
|
O:
0.0%
H:
0.87%
C:
0.69%
NVS
|
News
4 d
|
$89.49
-0.39%
0.01%
1.7M
|
Health Technology
|
-3.0%
|
O:
-1.25%
H:
0.0%
C:
0.0%
LLY
|
News
|
$342.1
-1.7%
0.12%
2.3M
|
Health Technology
|
0.06%
|
O:
1.48%
H:
0.34%
C:
-0.85%
BHC
|
$8.38
-1.64%
0.0%
4.7M
|
Health Technology
|
2.53%
|
O:
2.77%
H:
3.28%
C:
-0.23%
ABBV
|
News
|
$146.28
-0.76%
0.06%
4.6M
|
Health Technology
|
-0.03%
|
O:
0.15%
H:
0.0%
C:
0.0%
AMGN
|
News
|
$253.68
-0.47%
-0.47%
2.1M
|
Health Technology
|
-2.32%
|
O:
-1.76%
H:
0.0%
C:
0.0%
leo
pharma
global
report
therapeutics
psoriasis
market
Insights on the Alzheimer's Drugs Global Market to 2027 - Hospital Sector will Capture more Revenue in Upcoming Years
Published:
2023-01-25
(Crawled : 21:00)
- prnewswire.com
SNYNF
|
News
|
$97.85
0
|
Health Technology
|
-0.49%
|
O:
-0.49%
H:
0.0%
C:
0.0%
NVSEF
|
News
4 d
|
$90.0
0
|
Health Technology
|
-1.1%
|
O:
-1.1%
H:
0.0%
C:
0.0%
PFE
|
$43.79
-1.04%
0.0%
23M
|
Health Technology
|
-1.91%
|
O:
-1.87%
H:
0.0%
C:
0.0%
NVS
|
News
4 d
|
$89.49
-0.39%
0.01%
1.7M
|
Health Technology
|
-3.0%
|
O:
-1.25%
H:
0.0%
C:
0.0%
GSK
|
News
|
$35.3
-0.11%
0.14%
3.5M
|
Health Technology
|
0.94%
|
O:
0.89%
H:
0.0%
C:
0.0%
LLY
|
News
|
$342.1
-1.7%
0.12%
2.3M
|
Health Technology
|
0.06%
|
O:
1.48%
H:
0.34%
C:
-0.85%
ABT
|
News
|
$109.95
-1.01%
0.0%
4.9M
|
Health Technology
|
0.51%
|
O:
1.26%
H:
0.0%
C:
0.0%
SNY
|
News
|
$48.49
-0.66%
-0.66%
1.1M
|
Health Technology
|
-0.37%
|
O:
0.89%
H:
0.0%
C:
0.0%
global
alzheimer's
market
Lilly Plans to Invest Additional $450 million at Manufacturing Site in Research Triangle Park
Published:
2023-01-24
(Crawled : 12:00)
- prnewswire.com
LLY
|
News
|
$342.1
-1.7%
0.12%
2.3M
|
Health Technology
|
-0.02%
|
O:
11.05%
H:
0.0%
C:
-9.9%
research
China Anti-Rheumatic Drug Markets Report 2022-2027 Featuring Pfizer, F. Hoffmann-La Roche, UCB S.A., Eli Lilly and Company, & AbbVie Inc.
Published:
2023-01-24
(Crawled : 12:00)
- prnewswire.com
LLY
|
News
|
$342.1
-1.7%
0.12%
2.3M
|
Health Technology
|
-0.02%
|
O:
11.05%
H:
0.0%
C:
-9.9%
ABBV
|
News
|
$146.28
-0.76%
0.06%
4.6M
|
Health Technology
|
-1.53%
|
O:
-0.97%
H:
0.53%
C:
-0.26%
drug
abbvie
report
china
Global Cybersecurity Market Analysis Report 2022-2027 - Increasing Focus on Solution-centric Security Capabilities and Rising Vulnerabilities on Endpoint Devices
Published:
2023-01-24
(Crawled : 12:00)
- prnewswire.com
LLY
|
News
|
$342.1
-1.7%
0.12%
2.3M
|
Health Technology
|
-0.02%
|
O:
11.05%
H:
0.0%
C:
-9.9%
ABBV
|
News
|
$146.28
-0.76%
0.06%
4.6M
|
Health Technology
|
-1.53%
|
O:
-0.97%
H:
0.53%
C:
-0.26%
SPLK
A
|
$95.27
-0.3%
-0.3%
2.3M
|
Technology Services
|
5.57%
|
O:
2.6%
H:
1.85%
C:
-0.59%
MSFT
|
News
|
$248.16
0.07%
0.06%
26M
|
Technology Services
|
3.28%
|
O:
0.64%
H:
0.6%
C:
-0.19%
CYBR
|
$139.81
0.71%
2.95%
260K
|
Technology Services
|
5.57%
|
O:
3.52%
H:
1.37%
C:
0.01%
CHKP
|
$128.97
-0.36%
-0.36%
420K
|
Technology Services
|
-1.56%
|
O:
-2.03%
H:
1.12%
C:
-0.55%
global
report
cybersecurity
security
market
World Connected Logistics Markets Report 2022-2029: Rising Need for Efficient Warehouse Management Driving Growth with Increasing Adoption of IoT and Cloud Technologies
Published:
2023-01-24
(Crawled : 12:00)
- prnewswire.com
IBM
|
News
|
$134.39
-0.05%
0.08%
7.9M
|
Technology Services
|
-5.05%
|
O:
-0.1%
H:
0.0%
C:
0.0%
INFY
|
$18.66
-1.48%
-0.16%
5.4M
|
Technology Services
|
0.29%
|
O:
0.5%
H:
0.0%
C:
0.0%
HON
|
News
|
$208.16
-0.57%
-0.57%
2.1M
|
Producer Manufacturing
|
2.88%
|
O:
0.77%
H:
1.82%
C:
1.46%
LLY
|
News
|
$342.1
-1.7%
0.12%
2.3M
|
Health Technology
|
-0.02%
|
O:
11.05%
H:
0.0%
C:
-9.9%
ABBV
|
News
|
$146.28
-0.76%
0.06%
4.6M
|
Health Technology
|
-1.53%
|
O:
-0.97%
H:
0.53%
C:
-0.26%
INTC
|
News
|
$28.155
-6.43%
-7.46%
150M
|
Electronic Technology
|
-7.72%
|
O:
2.13%
H:
0.0%
C:
0.0%
management
report
for
growth
iot
cloud
HUTCHMED Announces License to Takeda to Develop and Commercialize Fruquintinib Outside China
Published:
2023-01-23
(Crawled : 10:00)
- biospace.com/
TAK
|
News
|
$16.03
-0.43%
0.0%
3.7M
|
Health Technology
|
-0.99%
|
O:
0.25%
H:
0.4%
C:
-0.25%
LLY
|
News
|
$342.1
-1.7%
0.12%
2.3M
|
Health Technology
|
0.17%
|
O:
0.19%
H:
0.0%
C:
0.0%
license
china
U.S. Food and Drug Administration Issues Complete Response Letter for Accelerated Approval of Donanemab
Published:
2023-01-19
(Crawled : 00:00)
- prnewswire.com
LLY
|
News
|
$342.1
-1.7%
0.12%
2.3M
|
Health Technology
|
-1.81%
|
O:
-1.98%
H:
0.0%
C:
0.0%
drug
for
approval
response
food
Lilly Confirms Date and Conference Call for Fourth-Quarter 2022 Financial Results Announcement
Published:
2023-01-19
(Crawled : 17:00)
- biospace.com/
LLY
|
News
|
$342.1
-1.7%
0.12%
2.3M
|
Health Technology
|
-3.14%
|
O:
-1.35%
H:
0.0%
C:
0.0%
announcement
conference
for
financial
results
Global Prescription Drugs Market Analysis Report 2022: Increasing Number of Chronic Diseases Worldwide will Continue to Fuel Growth - Forecast to 2027
Published:
2023-01-19
(Crawled : 17:00)
- prnewswire.com
TAK
|
News
|
$16.03
-0.43%
0.0%
3.7M
|
Health Technology
|
-0.68%
|
O:
0.03%
H:
0.0%
C:
0.0%
NVO
|
$138.09
0.4%
1.38%
1.1M
|
Health Technology
|
-1.59%
|
O:
0.14%
H:
0.0%
C:
0.0%
NVS
|
News
4 d
|
$89.49
-0.39%
0.01%
1.7M
|
Health Technology
|
-2.98%
|
O:
0.0%
H:
0.0%
C:
0.0%
JNJ
|
News
3 d
|
$168.23
-0.39%
-0.04%
6M
|
Health Technology
|
-1.86%
|
O:
-1.45%
H:
0.0%
C:
0.0%
GSK
|
News
|
$35.3
-0.11%
0.14%
3.5M
|
Health Technology
|
0.37%
|
O:
0.23%
H:
0.0%
C:
0.0%
LLY
|
News
|
$342.1
-1.7%
0.12%
2.3M
|
Health Technology
|
-3.14%
|
O:
-1.35%
H:
0.0%
C:
0.0%
BMY
|
News
|
$72.45
-0.74%
0.0%
5.4M
|
Health Technology
|
1.05%
|
O:
0.19%
H:
0.0%
C:
0.0%
ABBV
|
News
|
$146.28
-0.76%
0.06%
4.6M
|
Health Technology
|
-3.18%
|
O:
-2.16%
H:
0.0%
C:
0.0%
SNY
|
News
|
$48.49
-0.66%
-0.66%
1.1M
|
Health Technology
|
-2.51%
|
O:
-0.92%
H:
0.0%
C:
0.0%
GILD
F
|
$83.7
0.1%
0.1%
4.1M
|
Health Technology
|
-0.14%
|
O:
0.43%
H:
0.0%
C:
0.0%
AMGN
|
News
|
$253.68
-0.47%
-0.47%
2.1M
|
Health Technology
|
-3.58%
|
O:
-0.9%
H:
0.0%
C:
0.0%
global
report
growth
market
China's First and Only Approved Third-Generation BCR-ABL Inhibitor Olverembatinib Included into the 2022 National Reimbursement Drug List
Published:
2023-01-19
(Crawled : 04:00)
- prnewswire.com
LLY
|
News
|
$342.1
-1.7%
0.12%
2.3M
|
Health Technology
|
-3.14%
|
O:
-1.35%
H:
0.0%
C:
0.0%
SNY
|
News
|
$48.49
-0.66%
-0.66%
1.1M
|
Health Technology
|
-2.51%
|
O:
-0.92%
H:
0.0%
C:
0.0%
drug
approved
Worldwide Monoclonal Antibodies Industry to 2033 - Rising mAb Therapy Applications for Targeted Therapies Drives Growth
Published:
2023-01-18
(Crawled : 18:00)
- prnewswire.com
VTRS
|
$11.89
2.15%
2.1%
9.9M
|
Health Technology
|
-1.69%
|
O:
-0.17%
H:
0.25%
C:
-2.96%
TMO
|
News
|
$573.63
-0.65%
-0.03%
1.1M
|
Health Technology
|
-2.8%
|
O:
0.56%
H:
0.97%
C:
-1.87%
NVO
|
$138.09
0.4%
1.38%
1.1M
|
Health Technology
|
-1.04%
|
O:
0.57%
H:
0.84%
C:
-0.01%
NVS
|
News
4 d
|
$89.49
-0.39%
0.01%
1.7M
|
Health Technology
|
-4.04%
|
O:
0.08%
H:
0.01%
C:
-1.16%
JNJ
|
News
3 d
|
$168.23
-0.39%
-0.04%
6M
|
Health Technology
|
-3.3%
|
O:
-1.47%
H:
0.0%
C:
0.0%
GSK
|
News
|
$35.3
-0.11%
0.14%
3.5M
|
Health Technology
|
-0.67%
|
O:
-0.03%
H:
0.17%
C:
-1.01%
LLY
|
News
|
$342.1
-1.7%
0.12%
2.3M
|
Health Technology
|
-4.23%
|
O:
-1.13%
H:
0.0%
C:
0.0%
ABT
|
News
|
$109.95
-1.01%
0.0%
4.9M
|
Health Technology
|
-2.46%
|
O:
-0.16%
H:
0.33%
C:
-1.5%
SNY
|
News
|
$48.49
-0.66%
-0.66%
1.1M
|
Health Technology
|
-2.65%
|
O:
-0.14%
H:
0.0%
C:
0.0%
BIIB
A
|
$290.0
-0.66%
-0.66%
890K
|
Health Technology
|
1.46%
|
O:
0.26%
H:
0.0%
C:
0.0%
AZN
|
$65.54
-0.68%
-0.69%
3.1M
|
Health Technology
|
-6.71%
|
O:
1.36%
H:
0.33%
C:
-1.13%
AMGN
|
News
|
$253.68
-0.47%
-0.47%
2.1M
|
Health Technology
|
-5.38%
|
O:
0.0%
H:
0.41%
C:
-1.87%
for
therapy
growth
Innovent Announces Inclusion in the China National Reimbursement Drug List (NRDL) of TYVYT in Two New Indications, Olverembatinib for the First Listing, BYVASDA, HALPRYZA and SULINNO in Multiple New Indications
Published:
2023-01-18
(Crawled : 14:20)
- biospace.com/
LLY
|
News
|
$342.1
-1.7%
0.12%
2.3M
|
Health Technology
|
-4.23%
|
O:
-1.13%
H:
0.0%
C:
0.0%
SNY
|
News
|
$48.49
-0.66%
-0.66%
1.1M
|
Health Technology
|
-2.65%
|
O:
-0.14%
H:
0.0%
C:
0.0%
INCY
|
News
F
|
$85.66
-0.41%
-0.41%
930K
|
Health Technology
|
5.65%
|
O:
-0.21%
H:
1.66%
C:
1.46%
drug
tyvyt
for
china
AC Immune Partner Life Molecular Imaging Initiates Phase 3 Study of Tau PET Diagnostic PI-2620 for Alzheimer’s Disease
Published:
2023-01-18
(Crawled : 12:20)
- globenewswire.com
LLY
|
News
|
$342.1
-1.7%
0.12%
2.3M
|
Health Technology
|
-4.23%
|
O:
-1.13%
H:
0.0%
C:
0.0%
ACIU
|
$2.33
-2.92%
-3.0%
130K
|
Health Technology
|
-2.04%
|
O:
0.0%
H:
0.0%
C:
-4.9%
pi-2620
disease
for
diagnostic
life
tau
imaging
alzheimer’s
molecular
study
← Previous
1
2
3
4
5
6
7
8
9
…
56
57
Next →
Gainers vs Losers
66%
34%
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.